Aiforia's CE-IVD marked pathology models will be sold through PathAI's AISight Marketplace, widening their reach into US laboratories.
Roche told investors it wants research that needs fewer hands on deck, an ambition the company frames as AI independence.
The 95,000-square-foot center at Harvard's Enterprise Research Campus puts discovery scientists beside AI and data teams.
The first neuroscience target found through Recursion's $12B AI pact with Roche and Genentech is moving into an early discovery…